Headline
The latest stories from AHA Today.
Medicare will cover nationally Chimeric Antigen Receptor T-cell therapies approved by the Food and Drug Administration to treat certain cancers, as well as off-label uses recommended by compendia approved by the Centers for Medicare & Medicaid Services.
Offering a government insurance program reimbursing at Medicare rates as a public option on the health insurance exchanges could place as many as 55% of rural hospitals.
The AHA next month will launch an Action Community offering free monthly webinars, coaching, resources, in-person meetings and site visits to help hospitals and health systems integrate “age-friendly” health care.
The state of Florida and city of Philadelphia each declared public health emergencies last week to address hepatitis A outbreaks.
The National Association of Attorneys General yesterday urged congressional leaders to remove federal barriers to opioid use disorder treatment.
The number of naloxone prescriptions dispensed from retail pharmacies doubled in 2018, but access to the emergency opioid overdose treatment still varies widely, according to a report released today by the Centers for Disease Control and Prevention.
The Centers for Medicare & Medicaid Services will discontinue the Medicare Advantage Qualifying Payment Arrangement Incentive Demonstration due to low participation, the agency announced last week.
The AHA has elected seven new members to its Board of Trustees for three-year terms beginning Jan. 1.
Hospitals treated dozens of victims from mass shootings this weekend at a Walmart in El Paso, Texas, and hours later in downtown Dayton, Ohio, which together killed at least 31 people.
The Wyoming Department of Health plans to submit a waiver application that would expand Medicaid coverage to all Wyoming residents for air ambulance transportation.